|
1) Snider GL, Kleinerman J, Thurlbeck WM, et al. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am Rev Respir Dis. 1985; 132: 182-5
|
|
|
|
2) 日本呼吸器学会. COPD(慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第3版. 2009
|
|
|
|
|
|
3) Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration. 1993; 60: 354-8
|
|
|
|
|
4) 小谷敬太, 村田和子, 吉田祥二. 肺気腫と特発性肺線維症の併存症例における胸部CT像の評価. 断層映像研究会雑誌. 2004; 31: 25-9
|
|
|
|
|
5) Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005; 26: 586-93
|
|
|
|
|
|
6) 大谷秀雄, 金澤 實. 間質性肺炎・線維化病変とCOPD. COPD FRONTIER. 2007; 6: 149-53
|
|
|
|
|
|
7) 三嶋理晃. 2-1. 診断(喘息との異同, 気腫性病変と線維化病変の合併, 気腫型と非気腫型). COPD FRONTIER. 2009; 8: 152-7
|
|
|
|
|
|
8) 青柴和徹. 気腫化を合併した間質性肺炎. 医学のあゆみ. 2009; 229: 603-6
|
|
|
|
|
9) Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010; 15: 265-71
|
|
|
|
|
|
10) 中畑亜希子, 酒井文和, 臼井 裕, 他. 気腫性変化を伴う間質性肺炎の臨床的・画像的特徴. 厚生労働省科学研究 特発性肺線維症の予後改善を目指したサイクロスポリン＋ステロイド療法ならびにNアセチルシステイン吸入療法に関する臨床研究. 平成19年度研究報告書. 2007; p.102-6
|
|
|
|
|
|
11) Mejía M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009; 136: 10-5
|
|
|
|
|
|
12) Sergiacomi G, Bolacchi F, Cadioli M, et al. Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement. Radiology. 2010; 254: 601-8
|
|
|
|
|
|
13) Jankowich MD, Polsky M, Klein M, et al. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 2008; 75: 411-7
|
|
|
|
|
|
14) Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 2005; 99: 948-54
|
|
|
|
|
|
15) Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008; 53: 707-14
|
|
|
|
|
|
16) Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010; 35: 105-11
|
|
|
|
|
|
17) Kurashima K, Takayanagi N, Tsuchiya N, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology. 2010; 15: 843-8
|
|
|
|
|
|
18) Reynolds HY. Diagnostic and management strategies for diffuse interstitial lung disease. Chest. 1998; 113: 192-202
|
|
|
|
|
|
19) Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009; 9: 377-84
|
|
|
|
|
|
20) Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am J Respir Crit Care Med. 2005; 172: 1605; author reply 1605-6
|
|
|
|
|
|
21) Daniil Z, Koutsokera A, Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J. 2006; 27: 434
|
|
|
|
|
|
22) Hoyle GW, Li J, Finkelstein JB, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999; 154: 1763-75
|
|
|
|
|
|
23) Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med. 2005; 171: 1363-70
|
|
|
|
|
|
24) Fulkerson PC, Fischetti CA, Hassman LM, et al. Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol. 2006; 35: 337-46
|
|
|
|
|
|
25) Gauldie J, Kolb M, Ask K, et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc. 2006; 3: 696-702
|
|
|
|
|
|
26) Rogliani P, Mura M, Mattia P, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008; 102: 1753-61
|
|
|
|
|